- Home
- BBIO vs LLYVA Comparison
BBIO vs LLYVA Comparison
Compare BBIO & LLYVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- LLYVA
- Stock Information
- Founded
- BBIO 2015
- LLYVA 1991
- Country
- BBIO United States
- LLYVA United States
- Employees
- BBIO N/A
- LLYVA N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- LLYVA Broadcasting
- Sector
- BBIO Health Care
- LLYVA Industrials
- Exchange
- BBIO Nasdaq
- LLYVA Nasdaq
- Market Cap
- BBIO 5.6B
- LLYVA 5.9B
- IPO Year
- BBIO 2019
- LLYVA N/A
- Fundamental
- Price
- BBIO $36.08
- LLYVA $70.08
- Analyst Decision
- BBIO Strong Buy
- LLYVA
- Analyst Count
- BBIO 13
- LLYVA 0
- Target Price
- BBIO $48.33
- LLYVA N/A
- AVG Volume (30 Days)
- BBIO 2.5M
- LLYVA 100.8K
- Earning Date
- BBIO 02-20-2025
- LLYVA 01-01-0001
- Dividend Yield
- BBIO N/A
- LLYVA N/A
- EPS Growth
- BBIO N/A
- LLYVA N/A
- EPS
- BBIO N/A
- LLYVA N/A
- Revenue
- BBIO $217,765,000.00
- LLYVA N/A
- Revenue This Year
- BBIO $2,309.33
- LLYVA N/A
- Revenue Next Year
- BBIO N/A
- LLYVA $10.14
- P/E Ratio
- BBIO N/A
- LLYVA N/A
- Revenue Growth
- BBIO 2209.77
- LLYVA N/A
- 52 Week Low
- BBIO $21.62
- LLYVA $32.55
- 52 Week High
- BBIO $41.04
- LLYVA $72.88
- Technical
- Relative Strength Index (RSI)
- BBIO 73.73
- LLYVA 66.22
- Support Level
- BBIO $33.73
- LLYVA $63.91
- Resistance Level
- BBIO $36.24
- LLYVA $65.29
- Average True Range (ATR)
- BBIO 1.63
- LLYVA 1.32
- MACD
- BBIO 0.65
- LLYVA 0.30
- Stochastic Oscillator
- BBIO 97.63
- LLYVA 94.14
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About LLYVA Liberty Media Corporation Series A Liberty Live
Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's strategy for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.